Sage Therapeutics, Inc. (NASDAQ:SAGE) Receives $8.87 Consensus Price Target from Analysts
Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report) has earned a consensus rating of “Hold” from the seventeen ratings firms that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, fourteen have assigned a hold recommendation and two have given a buy recommendation to the […]
Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report) has earned a consensus rating of “Hold” from the seventeen ratings firms that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, fourteen have assigned a hold recommendation and two have given a buy recommendation to the […]
